Pfizer (NYSE:PFE) stock is a biopharmaceutical firm that had a magnificent breakout in 2021 as the worst of the pandemic sent COVID vaccine demand through the roof. Since that peak, it’s been a painful descent for shares of PFE, with the name now down around …
Is It Time to Invest in Pfizer? Exploring its 7% Dividend Yield and Growth Potential
